Mark W. Richards
AstraZeneca (United Kingdom)(GB)University of Leeds(GB)University of Leicester(GB)Institute of Structural and Molecular Biology(GB)
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Lung Cancer Treatments and Mutations, Cancer-related Molecular Pathways, Lung Cancer Research Studies, Ion channel regulation and function
Most-Cited Works
- → The metal-ion-dependent adhesion site in the Von Willebrand factor-A domain of α 2 δ subunits is key to trafficking voltage-gated Ca 2 + channels(2005)226 cited
- → Differential protein stability and clinical responses ofEML4-ALK fusion variants to various ALK inhibitors in advancedALK-rearranged non-small cell lung cancer(2016)213 cited
- → Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors(2016)182 cited
- → Crystal structure of EML1 reveals the basis for Hsp90 dependence of oncogenic EML4-ALK by disruption of an atypical β-propeller domain(2014)112 cited
- → Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs(2016)109 cited
- → Ca2+ channel β-subunits: structural insights AID our understanding(2004)107 cited